Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-mercaptobenzoate
2. Para-mercaptobenzoate
1. 1074-36-8
2. 4-sulfanylbenzoic Acid
3. 4-mercaptobenzoate
4. Benzoic Acid, 4-mercapto-
5. 4-mercapto-benzoic Acid
6. 4-thiobenzoic Acid
7. P-mercaptobenzoic Acid
8. Mfcd00016617
9. Benzoic Acid, P-mercapto-
10. Para-mercaptobenzoate
11. 4-mercapto Benzoic Acid
12. 4-carboxythiophenol
13. Paracarboxythiophenol
14. Nsc 32022
15. 4-carboxybenzenethiol
16. 4-sulfanylbenzoic Acid #
17. Schembl40593
18. Chembl98938
19. 4-mercaptobenzoic Acid, 99%
20. 4-mercaptobenzenecarboxylic Acid
21. Schembl18856223
22. Lmjxsoypaosipz-uhfffaoysa-
23. Dtxsid40148036
24. Zinc396167
25. Act01031
26. Nsc32022
27. Str03027
28. Nsc-32022
29. Akos009106886
30. Cs-w018038
31. Ps-4543
32. 4-mercaptobenzoic Acid, Technical Grade
33. Ac-15549
34. Db-040755
35. Ft-0618860
36. M1294
37. 4-mercaptobenzoic Acid, Technical Grade, 90%
38. En300-26533
39. Q-200488
40. F2182-0142
41. Z1270312062
| Molecular Weight | 154.19 g/mol |
|---|---|
| Molecular Formula | C7H6O2S |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 154.00885060 g/mol |
| Monoisotopic Mass | 154.00885060 g/mol |
| Topological Polar Surface Area | 38.3 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 128 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A CM-101 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CM-101, including repackagers and relabelers. The FDA regulates CM-101 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CM-101 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CM-101 supplier is an individual or a company that provides CM-101 active pharmaceutical ingredient (API) or CM-101 finished formulations upon request. The CM-101 suppliers may include CM-101 API manufacturers, exporters, distributors and traders.
CM-101 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CM-101 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CM-101 GMP manufacturer or CM-101 GMP API supplier for your needs.
A CM-101 CoA (Certificate of Analysis) is a formal document that attests to CM-101's compliance with CM-101 specifications and serves as a tool for batch-level quality control.
CM-101 CoA mostly includes findings from lab analyses of a specific batch. For each CM-101 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CM-101 may be tested according to a variety of international standards, such as European Pharmacopoeia (CM-101 EP), CM-101 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CM-101 USP).
LOOKING FOR A SUPPLIER?
